Home › Funds › ANTIPODES PARTNERS Ltd › NU

ANTIPODES PARTNERS Ltd position in NU

NU HLDGS LTD · Financials

ANTIPODES PARTNERS Ltd reported holding 3,340,760 shares of NU (NU HLDGS LTD) in its Q3 2026 13F filing — a position valued at US$42.3M, representing 0.78% of its reported portfolio and ranking #46 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed NU holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.34M sh
Reported value held$42.29M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ANTIPODES PARTNERS Ltd's NU position evolved

ANTIPODES PARTNERS Ltd first disclosed a stake in NU in Q3 2023 at 27,905 shares (US$203K). The position peaked in Q2 2026 at 4,689,670 shares, worth US$62.7M. Across 13 filings, ANTIPODES PARTNERS Ltd increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,340,760 shares valued at US$42.3M — a reduction of -1,348,910 shares quarter over quarter.. Notable position changes include a 56% increase in Q1 2025 (shares rose 34% over the following quarter), a 7572% increase in Q2 2025 (shares rose 17% over the following quarter), a 38% increase in Q3 2025 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 27.91K $203.00K New
Q4 2023 29.65K $246.00K Add
Q1 2024 22.38K $267.00K Reduce
Q2 2024 16.94K $219.27K Reduce
Q3 2024 15.42K $210.46K Reduce
Q4 2024 21.16K $219.19K Add
Q1 2025 33.04K $338.35K Add
Q2 2025 2.53M $34.78M Add
Q3 2025 3.49M $55.91M Add
Q4 2025 3.41M $57.05M Reduce
Q1 2026 4.19M $60.25M Add
Q2 2026 4.69M $62.65M Add
Q3 2026 3.34M $42.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NU and 13F data

NU (NU HLDGS LTD) is a Financials company. 33 other funds we track also report a position in NU — the largest reported positions include a16z Perennial Management, L.P. (US$18.28B), Baillie Gifford & Co (US$3.01B), WCM INVESTMENT MANAGEMENT, LLC (US$916.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NU

All NU fund holders →

FAQ

How long has ANTIPODES PARTNERS Ltd held NU?

ANTIPODES PARTNERS Ltd has disclosed NU holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ANTIPODES PARTNERS Ltd's current position in NU?

As of Q3 2026, ANTIPODES PARTNERS Ltd holds 3.34M shares of NU (NU HLDGS LTD), valued at $42.29M, representing 0.78% of its reported portfolio and ranking #46.

Has ANTIPODES PARTNERS Ltd been buying or selling NU?

In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd reduced its position in NU. The position peaked in Q2 2026 at 4.69M shares.

Which other funds hold NU?

Other major institutional holders of NU include a16z Perennial Management, L.P., Baillie Gifford & Co, WCM INVESTMENT MANAGEMENT, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.